Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Name: Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
SKU: 22778
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 49 No. 1 Articles 2019 Tags: autonomic symptoms, Camilla Callegari, Celeste Isella, cognitive-impairment, Fabiana Pettenon, Giulia Lucca, Ivano Caselli, Marcello Diurni, Marta Ielmini, Nicola Poloni, paroxetine, post-menopausal depression, vortioxetine

Description

Description

Evidence-Based Medicine

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

By Camilla Callegari, Marta Ielmini, Ivano Caselli, Giulia Lucca, Celeste Isella, Marcello Diurni, Fabiana Pettenon, Nicola Poloni

28-43_PB-49-1-2019-Callegari

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Description

Evidence-Based Medicine

Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes

Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required

Paroxetine Treatment of Depression in Late Life

Paroxetine Treatment of Major Depressive Disorder

Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study

Description

Evidence-Based Medicine

Related products

Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes

Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required

Paroxetine Treatment of Depression in Late Life

Paroxetine Treatment of Major Depressive Disorder